K Number
K060474
Device Name
LISFRANC PLATE
Manufacturer
Date Cleared
2006-08-03

(161 days)

Product Code
Regulation Number
888.3030
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The NEWDEAL Lisfranc Plates are intended for fractures, fusions, osteotomies and replantations of small bones at the tarsometatarsal joints (Lisfranc joints)

Device Description

The NEWDEAL® Lisfranc Plate consists of an osteosynthesis plate designed to bridge the tarsometatarsal joints (Lisfranc joints). It is available in different sizes, and is implanted using screws and washers. The NEWDEAL® locking system includes as many fixation screws as there are threaded lipped sockets on the plate and as many washers as implanted screws. The NEWDEAL® screws must be driven into the bone through the holes in the plate. The system is locked by means of washers drilled into the threaded lipped socket at the top of each hole, thus blocking each screw head.

AI/ML Overview

Here's an analysis of the provided 510(k) summary regarding the Newdeal Lisfranc Plates, focusing on acceptance criteria and supporting studies:

This 510(k) summary describes a traditional device clearance process for a new medical implant, not an AI/ML-driven diagnostic device. Therefore, many of the requested categories (such as sample sizes for test/training sets, number of experts, adjudication methods, MRMC studies, standalone performance, and ground truth types) are not applicable or not provided in this type of submission. The focus for mechanical devices like bone plates is on performance testing against a predicate device and material specifications.

Here's a breakdown of the available information:


Description of Acceptance Criteria and Study Findings

1. Table of Acceptance Criteria and Reported Device Performance

CriterionAcceptance MetricReported Device Performance
Mechanical PerformancePerformance testing (e.g., strength, durability, fatigue resistance) that demonstrates substantial equivalence to a legally marketed predicate device. This typically involves biomechanical tests to ensure the new device can withstand the same forces and stresses as the predicate in a simulated environment, without failure or significant difference in performance.Performance testing was conducted and the "Lisfranc Plates performed comparably in all mechanical aspects relevant to the intended use." (This is an inference based on the "comparable results" statement, as specific metrics are not detailed in the summary.)
Material/BiocompatibilityMaterials used are biocompatible and meet established standards for medical devices implanted in the human body.The document implies that the materials are standard for such devices, as no new material issues are raised and the device is deemed substantially equivalent. Specific material composition or biocompatibility test results are not detailed.
Design/FunctionalityThe plate design, screw locking mechanism, and overall system function are safe and effective for their intended use in stabilizing Lisfranc joints, consistent with the predicate device.The device description outlines a locking system with threaded lipped sockets and screws, operating similarly to existing technology. The conclusion states no new issues of scientific technology, safety, or effectiveness are raised.
Intended UseThe device is suitable for its stated indications (fractures, fusions, osteotomies, replantations of small bones at the tarsometatarsal joints).The intended use is clearly stated and aligns with the function of bone plates for these types of injuries/procedures.

Study that proves the device meets acceptance criteria:

The primary study cited is performance testing conducted compared to a legally marketed predicate device. The key finding is that the Lisfranc Plates demonstrated "comparable results" in all mechanical aspects relevant to the intended use when compared to the predicate device. This implies that the device met the mechanical performance standards set by the predicate.


2. Sample size used for the test set and the data provenance

  • Not Applicable / Not Provided. For mechanical performance testing of an orthopedic implant, "test set" typically refers to the number of devices or constructs tested in a laboratory setting. This 510(k) summary does not specify the number of samples tested biomechanically. The concept of "data provenance" (country of origin, retrospective/prospective) is not relevant for this type of mechanical testing submission.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

  • Not Applicable / Not Provided. "Ground truth" established by experts is typically for diagnostic imaging or clinical outcome data. For mechanical devices, the "ground truth" is defined by established engineering and biomechanical standards and the performance of predicate devices.

4. Adjudication method for the test set

  • Not Applicable / Not Provided. Adjudication methods (like 2+1, 3+1) are used for expert review of clinical cases or diagnostic interpretations, which is not relevant for a mechanical device performance study described here. The "adjudication" for mechanical testing would be the interpretation of engineering data by qualified biomechanical engineers.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance

  • Not Applicable. This device is a bone plate, not an AI-driven diagnostic or assistive technology. Therefore, an MRMC study is irrelevant.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

  • Not Applicable. This device is a physical bone plate, not an algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

  • For this type of device, the "ground truth" is based on:
    • Biomechanical engineering standards: Established testing protocols for strength, fatigue, pull-out strength, etc., relevant to bone fixation.
    • Predicate device performance: The performance characteristics of the legally marketed predicate device serve as the benchmark for substantial equivalence.
    • Material standards: Compliance with recognized standards for biocompatibility and material properties.

8. The sample size for the training set

  • Not Applicable / Not Provided. The concept of "training set" applies to AI/ML models. This is a mechanical device.

9. How the ground truth for the training set was established

  • Not Applicable / Not Provided. As there is no training set mentioned, this question is not relevant.

In summary: The 510(k) for the Lisfranc Plates relies on the principle of substantial equivalence to existing, legally marketed predicate devices. The "study" proving this equivalence is mechanical performance testing that demonstrates comparable results to the predicate. The detailed methodologies commonly found in AI/ML or clinical trial submissions (like expert panels, detailed sample sizes, adjudication, etc.) are not part of this type of traditional device submission.

{0}------------------------------------------------

510(K) SUMMARY

K060474

Lisfranc Plates

AUG - 3 2006

Submitter's name and address:

Newdeal SAS 10, place d'Helvétie 69006 Lyon, France Tel: +33 4 37 47 51 51 Fax: +33 4 37 47 51 52

Contact person and telephone number

Morgane Grenier Regulatory and Clinical Affairs Director Newdeal SAS 10, place d'Helvétie 69006 Lyon, France Tel: +33 4 37 47 51 51 Fax: +33 4 37 47 51 52

Alternate Contacts

Authorized Agent in the United States

Judith E. O'Grady, RN, MSN Sr. Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, NJ 08536, USA Tel: (609) 936-2311 Fax: (609) 275-9445 E-mail: jogrady@integra-ls.com

Date Summary was prepared:

July 17, 2006

Name of the device:

Proprietary Name:Lisfranc Plate
Common Name:Plate, Fixation, Bone
Classification Name:Single/multiple component metallic bone fixation appliances andaccessories (21CFR 888.3030)
Device Product Code:HRS
Classification Panel:Orthopedic

Substantial Equivalence:

The Lisfranc Plate is substantially equivalent to the Acumed Lower Extremity Congruent Bone Plate System, K033639, the Synthes Modular Foot System - 2.7 mm Module, K010321 and the Synthes Modular Foot System, K001941.

{1}------------------------------------------------

Device Description:

Device Description:
The NEWDEAL® Lisfranc Plate consists of an osteosynthesis plate designed to bridge the The NEWDEAL "Listranc joints). It is available in different sizes, and is implanted using tarsometatisal Journs (Listiane Johns). It is a rand washers. The NEWDEAL® locking system NCWDEAL "focking system manon ove are threaded lipped sockets on the plate and as many includes as mally fixation serews as there are the care a single implant/screw wasners as implanted scrows. The NETH Dis screws must be driven into the bone through the holes in the plate. The system is locked by means of washers drilled into the threaded lipped socket at the top of each hole, thus blocking each screw head.

Intended Use:

The NEWDEAL Lisfranc Plates are intended to be used for fractures, fusions, osteotomies The NEW DEALL Boxmall bones of the tarsometatarsal joints (Lisfranc joints).

Testing and Test Results:

Performance testing was conducted compared to a legally marketed predicate device. The I cronnames results was in a between the Lisfranc Plates and the predicate device.

Conclusion

sion The Newton Lower Extremity Congruent Bone Plate System, K033639 the devices, the Acaned 20ws. Black 2010321 and the Synthes Modular Foot System, K001941.

The Newdeal Lisfranc Plates do not raise any new issues of scientific technology, safety or effectiveness

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features a stylized eagle with three heads, representing the department's focus on health, human services, and science. The words "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" are arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG - 3 2006

Newdeal SA c/o Ms. Judith O'Grady Sr. VP, Regulatory Affairs Integra Lifesciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536

K060474 Re:

Trade/Device Name: Lisfranc Plate Regulation Number: 21 CFR 888.3030 Regulation Namber. 21 OF No 0015 000
Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: HRS Dated: July 17, 2006 Received: July 18, 2006

Dear Ms. O'Grady:

We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your bection of the device is substantially equivalent (for the indications ferenced above und have active development to legally marketed predicate devices marketed in interstate for use stated in the encrosale) to regard mannent date of the Medical Device Amendments, or to comments provision of they 20, 1978, are eccordance with the provisions of the Federal Food, Drug, devices that have been recuire approval of a premarket approval application (PMA). alle Cosment Act (Act) that do not required to the general controls provisions of the Act. The r ou may, mererore, manot the Act include requirements for annual registration, listing of general controls provisions of the rece labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (600 world). Existing major regulations affecting your device can
may be subject to such additional controls. Existing major regulations FDA an may be subject to suen adatterial resultsions, Title 21, Parts 800 to 898. In addition, FDA may be found in the Couv acements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that I DA s issualled of a buice complies with other requirements of the Act that IDA has made a decerminations administered by other Federal agencies. You must

{3}------------------------------------------------

comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,
Herbert Levenson

V Mark N. Melkerson, M.S. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use

510(k) Number (if known): K060474

Device Name: Lisfranc Plates

Indications For Use:

The NEWDEAL Lisfranc Plates are intended for fractures, fusions, osteotomies and replantations of small bones at the tarsometatarsal joints (Lisfranc joints)

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Herbert Vern Page 1 of 1

(Division Sign-Off) Division of General, Restorative, and Neurological Devices

510(k) Number K060474

§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.

(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.